CD47 and neoplasm: Furthermore, CD47 is also an important marker for M2-type TAMs, and anti-CD47 therapy can reprogram TAMs to proinflammatory (M1-type) macrophages to kill tumor cells and prevent tumor metastases in human solid tumors (187).